Integrated Diagnostics Holdings PLC Award from the College of American Pathologists (9004F)

TIDMIDHC

RNS Number : 9004F

Integrated Diagnostics Holdings PLC

26 February 2018

26 February 2018

Integrated Diagnostics Holdings' central Mega Lab in Cairo earns certification from College of American Pathologists

The state of the art facility, operational since mid-2015, is the only medical diagnostics laboratory in Egypt with CAP certification

(London) - Integrated Diagnostics Holdings ("IDH"), IDHC on the London Stock Exchange, a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, announced today that the Group has been awarded certification for its Cairo Mega Lab from the College of American Pathologists (CAP).

The Mega Lab, inaugurated in June 2015, replaced two smaller, independent "A-labs," one of which was CAP certified.

The College of American Pathologists is the world's largest association composed exclusively of pathologists certified by the American Board of Pathology. It is widely considered the leader in laboratory quality assurance globally. The CAP Laboratory Accreditation Program accredits the entire spectrum of laboratory test disciplines with the most scientifically rigorous customised checklist requirements.

IDH's Mega Lab is the only private laboratory in Egypt to receive this distinguished certification.

Dr. Hend El Sherbini, CEO, said: "Diagnostic testing is critical to quality healthcare. We are playing a pivotal role in improving healthcare outcomes among the resource-poor populations we serve and know that can only be accomplished by providing the highest-quality services for the prevention and early detection of disease. The international accreditation of our facilities constructs a competitive barrier to entry to our markets and, as importantly, imparts an assurance of quality and safety that engenders strong loyalty among our valued corporate as well as individual customers."

IDH operates an asset-light, scalable "Hub, Spoke and Spike" business model in which its Mega Lab functions as the central "Hub." Equipped for all services and tests offered by the Group, the Mega lab supports a network of 382 branch laboratories across four countries in the Middle East and Africa. The Mega Lab is very much a testament to the Company's institutional capacity to realise its vision to make modern medical diagnostics more accessible to all of the emerging markets it serves. Building its Mega Lab de novo in 2015, IDH constructed a state-of-the-art facility with ample excess capacity in preparation for the rapid expansion it has successfully been executing in recent years.

This news of the Mega Lab's CAP certification follows the recent announcement of the Group's investment in Nigeria, which not only gives the Company a foothold in Africa's largest and most populous country, but broadens its diagnostic service officering to include radiology.

IDH will report its financial results for the 2017 year on 21 March 2018.

-ENDS-

Media enquiries

Integrated Diagnostics Holdings

Sherif El-Ghamrawi

Investor Relations Director

T: [phone] | M: [phone] | [e-mail]

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCDMGZZLVGGRZG

(END) Dow Jones Newswires

February 26, 2018 04:49 ET (09:49 GMT)